Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.
Testosterone was isolated from samples and also synthesized in 1935.
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
Cetero Research, San Antonio, Texas, United States
Centex Research, Houston, Texas, United States
La Fe University Hospital. Department of Obstetrics and Gynecology, Valencia, Spain
Gulhane School of Medicine, Ankara, Turkey
Mayo Clinic, Rochester, Minnesota, United States
Millard Fillmore Gates Hospital, Buffalo, New York, United States
115 Flint Road, Williamsville, New York, United States
Dipartimento di Fisiopatologia Medica - Policlinico Umberto I, Rome, Italy
Policlinico Umberto I Hospital - Sapienza University, Rome, Italy
Massachusetts General Hospital, Boston, Massachusetts, United States
Tameside Hospital NHS Foundatoin Trust, Ashton under Lyne, United Kingdom
Tameside General Hospital, Ashton-under-Lyne, Lancashire, United Kingdom
University of California, San Diego, San Diego, California, United States
VA San Diego Healthcare System, San Diego, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.